Multimodality Imaging of Pericardial Diseases

  • Mouaz H. Al-Mallah
  • Fatimah Almasoudi
  • Mohamed Ebid
  • Amjad M. Ahmed
  • Abdelrahman Jamiel
Imaging (Q Truong, Section Editor)
  • 188 Downloads
Part of the following topical collections:
  1. Topical Collection on Imaging

Opinion statement

Pericardial diseases have changed their epidemiology in the past few years. With the aging population and decreasing incidence of communicable diseases, the causes of pericardial diseases have significantly changed from infectious and malignant to postradiation and cardiac surgery causes. Despite that, pericardial diseases remain difficult to diagnose. The accurate and timely diagnosis of these diseases is essential to avoid the late sequela of pericardial constriction and pericardial cirrhosis. Echocardiography remains the first test of choice for the assessment of patients with suspected pericardial diseases. Most patients with acute pericarditis have a self-limiting course and do not need further imaging. However, in the era of multimodality imaging, other modalities, namely, computed tomography (CT) and magnetic resonance imaging (CMR), are often utilized in complex cases. These two modalities provide a wide-open view of the pericardium and adjacent structures. They have high resolution to assess pericardial calcification, a hallmark of many diseases especially tuberculous constrictive pericarditis. CMR is also unique in its ability to assess pericardial late gadolinium enhancement (LGE) and edema. These have been recently suggested to be very important in the progression from acute pericarditis to constrictive pericarditis. In addition, they provide prognostic value to assess which patients are at high risk of developing heart failure and resource utilization. Thus, in the current era, patients with suspected complex pericardial diseases will need a multimodality approach rather than a single modality approach.

Keywords

Pericardial disease Magnetic resonance imaging Computed tomography Imaging 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: Of importance •• Of major importance

  1. 1.
    Yusuf SW, Hassan SA, Mouhayar E, Negi SI, Banchs J, O’Gara PT. Pericardial disease: a clinical review. Expert Rev Cardiovasc Ther. 2016;14:525–39.CrossRefPubMedGoogle Scholar
  2. 2.
    Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, et al. Task Force on the D and Management of Pricardial Diseases of the European Society of C. Guidelines on the diagnosis and management of pericardial diseases executive summary: the task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25:587–610.CrossRefPubMedGoogle Scholar
  3. 3.
    Kireyev D, Hung J. Pericardial disease. Card Imaging Clin Pract: Springer; 2016: 247.Google Scholar
  4. 4.
    Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004;363:717–27.CrossRefPubMedGoogle Scholar
  5. 5.
    Hoit BD. Imaging the pericardium. Cardiol Clin. 1990;8:587–600.PubMedGoogle Scholar
  6. 6.
    Al-Mallah M, Kwong RY. Assessing pericardial disease by CMR. Cardiovasc Magn Reson Imaging. Humana Press;2008: 467.Google Scholar
  7. 7.
    Spodick DH. Acute pericarditis: current concepts and practice. JAMA. 2003;289:1150–3.CrossRefPubMedGoogle Scholar
  8. 8.
    LeWinter MM. Acute pericarditis. N Engl J Med. 2014;371:2410–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Bogaert J, Cruz I, Voigt J-U, Sinnaeve P, Imazio M. Value of pericardial effusion as imaging biomarker in acute pericarditis, do we need to focus on more appropriate ones? Int J Cardiol. 2015;191:284–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Sagrista-Sauleda J, Merce AS, Soler-Soler J. Diagnosis and management of pericardial effusion. World J Cardiol. 2011;3:135–43.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, et al. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes. J Am Coll Cardiol. 2015;66:1378–91.CrossRefPubMedGoogle Scholar
  12. 12.
    Wang ZJ, Reddy GP, Gotway MB, Yeh BM, Hetts SW, Higgins CB. CT and MR imaging of pericardial disease. Radiographics. 2003;23:S167–80.CrossRefPubMedGoogle Scholar
  13. 13.
    Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–64.CrossRefPubMedGoogle Scholar
  14. 14.
    Rehman KA, Betancor J, Xu B, Kumar A, Rivas CG, Sato K, et al. Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: insights and pathophysiology. Clin Cardiol. 2017;  https://doi.org/10.1002/clc.22770.
  15. 15.
    Verhaert D, Gabriel RS, Johnston D, Lytle BW, Desai MY, Klein AL. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging. 2010;3:333–43.CrossRefPubMedGoogle Scholar
  16. 16.
    Ristić AD, Imazio M, Adler Y, Anastasakis A, Badano LP, Brucato A, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35:2279–84.CrossRefPubMedGoogle Scholar
  17. 17.
    Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26:965–1012 e15.CrossRefPubMedGoogle Scholar
  18. 18.
    Al-Mallah M, Kwong RY. Clinical application of cardiac CMR. Rev Cardiovasc Med. 2009;10:134–41.PubMedGoogle Scholar
  19. 19.
    Al-Mallah MH. Introduction to the special issue: myocardial imaging in heart failure. Heart Fail Rev. 2017;22:381–3.CrossRefPubMedGoogle Scholar
  20. 20.
    Palmer WC, Kurklinsky A, Lane G, Ussavarungsi K, Blackshear JL. Cardiac tamponade due to low-volume effusive constrictive pericarditis in a patient with uncontrolled type II autoimmune polyglandular syndrome. Acute Card Care. 2014;16:23–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Porta-Sánchez A, Sagristà-Sauleda J, Ferreira-González I, Torrents-Fernández A, Roca-Luque I, García-Dorado D. Constrictive pericarditis: etiologic spectrum, patterns of clinical presentation, prognostic factors, and long-term follow-up. Rev Esp Cardiol (Engl Ed). 2015;68:1092–100.CrossRefGoogle Scholar
  22. 22.
    Welch TD, Ling LH, Espinosa RE, Anavekar NS, Wiste HJ, Lahr BD, et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circ Cardiovasc Imaging. 2014;7:526–34.CrossRefPubMedGoogle Scholar
  23. 23.
    Klein AL, Cohen GI, Pietrolungo JF, White RD, Bailey A, Pearce GL, et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy by Doppler transesophageal echocardiographic measurements of respiratory variations in pulmonary venous flow. J Am Coll Cardiol. 1993;22:1935–43.CrossRefPubMedGoogle Scholar
  24. 24.
    •• Alraies MC, Aljaroudi W, Yarmohammadi H, Yingchoncharoen T, Schuster A, Senapati A, et al. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. Am J Cardiol. 2015;115:542–7. The aim of this study was to assess the utility of CMR in the management of RP compared with standard therapy. A total of 507 consecutive patients with RP after the first attack, all of whom were treated with colchicine and nonsteroidal anti-inflammatory drugs as first-line therapy, were retrospectively evaluated. CMR-guided therapy modulates the management of RP. This approach decreased pericarditis recurrence and exposure to steroids.CrossRefPubMedGoogle Scholar
  25. 25.
    Alraies MC, Klein AL. Q: Should we still use electrocardiography to diagnose pericardial disease? Cleve Clin J Med. 2013;80:97–100.CrossRefPubMedGoogle Scholar
  26. 26.
    Khawaja OA, Shaikh KA, Al-Mallah MH. Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents. Am J Cardiol. 2010;106:742–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Al-Mallah MH, Aljizeeri A, Villines TC, Srichai MB, Alsaileek A. Cardiac computed tomography in current cardiology guidelines. J Cardiovasc Comput Tomogr. 2015;9:514–23.CrossRefPubMedGoogle Scholar
  28. 28.
    Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney DW, Seward JB, et al. Constrictive pericarditis in the modern era evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Talreja DR, Edwards WD, Danielson GK, Schaff HV, Tajik AJ, Tazelaar HD, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Sechtem U, Tscholakoff D, Higgins CB. MRI of the abnormal pericardium. Am J Roentgenol. 1986;147:245–52.CrossRefGoogle Scholar
  31. 31.
    Gentry J, Klein AL, Jellis CL. Transient constrictive pericarditis: current diagnostic and therapeutic strategies. Curr Cardiol Rep. 2016;18:41.CrossRefPubMedGoogle Scholar
  32. 32.
    Chinnaiyan KM, Bilolikar AN, Walsh E, Wood D, DePetris A, Gentry R, et al. CT dose reduction using prospectively triggered or fast-pitch spiral technique employed in cardiothoracic imaging (the CT dose study). J Cardiovasc Comput Tomogr. 2014;8:205–14.CrossRefPubMedGoogle Scholar
  33. 33.
    Al-Mallah MH, Aljizeeri A, Alharthi M, Alsaileek A. Routine low-radiation-dose coronary computed tomography angiography. Eur Heart J Suppl. 2014;16:B12–6.CrossRefGoogle Scholar
  34. 34.
    Qureshi WT, Alirhayim Z, Khalid F, Al-Mallah MH. Prognostic value of extracardiac incidental findings on attenuation correction cardiac computed tomography. J Nucl Cardiol. 2016;23:1266–74.CrossRefPubMedGoogle Scholar
  35. 35.
    Aljizeeri A, Sulaiman A, Alhulaimi N, Alsaileek A, Al-Mallah MH. Cardiac magnetic resonance imaging in heart failure: where the alphabet begins! Heart Fail Rev. 2017;22:385–99.CrossRefPubMedGoogle Scholar
  36. 36.
    Al-Mallah MH, Shareef MN. The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy. Heart Fail Rev. 2011;16:369–80.CrossRefPubMedGoogle Scholar
  37. 37.
    Al-Mallah MH, Keteyian SJ, Brawner CA, Whelton S, Blaha MJ. Rationale and design of the Henry Ford Exercise Testing Project (the FIT project). Clin Cardiol. 2014;37:456–61.CrossRefPubMedGoogle Scholar
  38. 38.
    Frank H, Globits S. Magnetic resonance imaging evaluation of myocardial and pericardial disease. J Magn Reson Imaging. 1999;10:617–26.CrossRefPubMedGoogle Scholar
  39. 39.
    Young PM, Glockner JF, Williamson EE, Morris MF, Araoz PA, Julsrud PR, et al. MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation. Int J Cardiovasc Imaging. 2012;28:1099–109.CrossRefPubMedGoogle Scholar
  40. 40.
    Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur Radiol. 2006;16:569–74.CrossRefPubMedGoogle Scholar
  41. 41.
    Pinamonti B, Habjan S, De Luca A, Proclemer A, Morea G, Abate E, et al. Work-up and management of constrictive pericarditis: a critical review. G Ital Cardiol. 2016;17:197–207.Google Scholar
  42. 42.
    Glower DD. Sticking points in magnetic resonance diagnosis of constrictive pericarditis. J Thorac Cardiovasc Surg. 2016;151:1356–7.CrossRefPubMedGoogle Scholar
  43. 43.
    Mullen L, Chew PG, Frost F, Ahmed A, Khand A. Hyperenhancement of the pericardium on cardiac magnetic resonance imaging: a marker of acute inflammation and neovascularization or a chronic fibrotic state? Cardiology. 2016;133:239–41.CrossRefPubMedGoogle Scholar
  44. 44.
    Rienmüller R, Gröll R, Lipton MJ. CT and MR imaging of pericardial disease. Radiol Clin. 2004;42:587–601.CrossRefGoogle Scholar
  45. 45.
    Feng D, Glockner J, Kim K, Martinez M, Syed IS, Araoz P, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124:1830–7.CrossRefPubMedGoogle Scholar
  46. 46.
    Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. J Am Coll Cardiol Img. 2011;4:1180–91.CrossRefGoogle Scholar
  47. 47.
    •• Kumar A, Sato K, Yzeiraj E, Betancor J, Lin L, Tamarappoo BK, et al. Quantitative pericardial delayed hyperenhancement informs clinical course in recurrent pericarditis. JACC Cardiovasc Imaging. 2017;  https://doi.org/10.1016/j.jcmg.2016.10.020. This is a retrospective cohort study of 159 patients with RP who underwent DHE imaging and had a follow-up period of more than 6 months. Pericardial inflammation was quantified on short-axis DHE sequences by contouring the pericardium, selecting normal septal myocardium as a reference region, and then quantifying the pericardial signal that was > 6 SD above the reference. Quantitative assessment of pericardial DHE was associated with clinical outcomes among patients with RP and provided incremental information regarding the clinical course of patients with RP.
  48. 48.
    •• Cremer PC, Tariq MU, Karwa A, Alraies MC, Benatti R, Schuster A, et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Circ Cardiovasc Imaging. 2015;8:e003125. This study included 41 consecutive patients with constrictive pericarditis who had a cardiovascular magnetic resonance study with DHE prior to the initiation of anti-inflammatory medications. In patients with constrictive pericarditis treated with anti-inflammatory therapy, a quantitative assessment of pericardial DHE can provide incremental information to predict clinical improvement when added to clinical factors and Westergren sedimentation rates.CrossRefPubMedGoogle Scholar
  49. 49.
    Thavendiranathan P, Verhaert D, Walls MC, Bender JA, Rajagopalan S, Chung Y-C, et al. Simultaneous right and left heart real-time, free-breathing CMR flow quantification identifies constrictive physiology. J Am Coll Cardiol Img. 2012;5:15–24.CrossRefGoogle Scholar
  50. 50.
    Oh JK, Chang S-A, Choe Y-H, Young PM. CMR imaging for diastolic hemodynamic assessment: fantasy or reality? J Am Coll Cardiol Img. 2012;5:25–7.CrossRefGoogle Scholar
  51. 51.
    Patel J, Park C, Michaels J, Rosen S, Kort S. Pericardial cyst: case reports and a literature review. Echocardiography. 2004;21:269–72.CrossRefPubMedGoogle Scholar
  52. 52.
    Cangemi V, Volpino P, Gauldi G, Polettini E. Pericardial cysts of the mediastinum. J Cardiovasc Surg. 1999;40:909.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Mouaz H. Al-Mallah
    • 1
    • 2
    • 3
    • 4
  • Fatimah Almasoudi
    • 1
  • Mohamed Ebid
    • 1
  • Amjad M. Ahmed
    • 1
    • 2
  • Abdelrahman Jamiel
    • 1
    • 2
  1. 1.King Abdulaziz Cardiac Center, King Abdulaziz Medical CityMinistry of National Guard - Health AffairsRiyadhSaudi Arabia
  2. 2.King Saud bin Abdulaziz University for Health SciencesRiyadhSaudi Arabia
  3. 3.King Abdullah International Medical Research CenterRiyadhSaudi Arabia
  4. 4.Division Head, Cardiac Imaging, King Abdulaziz Cardiac Center, King Abdulaziz Medical City for National GuardKing Saud bin Abdulaziz University for Health SciencesRiyadhSaudi Arabia

Personalised recommendations